[HTML][HTML] Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology–ASBAI

FM Aarestrup, EA Taketomi, CES Galvão… - World Allergy …, 2022 - Elsevier
Abstract Background Allergen Immunotherapy (AIT) represents one of the pillars in the
treatment of allergic diseases. AIT is the only therapeutic strategy with curative potential …

Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?

GF Wandalsen, FM Aarestrup… - Current Opinion in Allergy …, 2024 - journals.lww.com
Despite the numerous studies carried out to identify the best biomarker to evaluate the
response to AIT, there is still much disagreement, and clinical assessment (symptoms …

Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy

S Garrido-Fernández, DG Fernández, GS López… - …, 2024 - Taylor & Francis
Aim: Sublingual immunotherapy (SLIT) changes history of allergic respiratory disease
(ARD). However, adherence is a barrier for optimal outcomes. Patients & methods: In the …

Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective …

M Di Gioacchino, L Della Valle, R Mangifesta… - Journal of Clinical …, 2022 - mdpi.com
Background: real-life studies are encouraged to evaluate the effectiveness and safety of
allergen immunotherapy (AIT). In this context, a retrospective cohort study was conducted to …